SEC Form 4 · accession 0001209191-15-081672
BG Medicine, Inc. · BGMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Noubar Afeyan
Director · 10% Owner
Period of report
Nov 18, 2015
Accepted (ET)
Nov 20, 2015 · 5:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001407038
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.52 | Nov 18, 2015 | A | 5,000 | A | — | Nov 18, 2025 | Common Stock | 5,000 | 5,000 | D |
Explanation of responses
- F1The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy for service as a director during 2015. The option vests as to one hundred percent of the shares on November 18, 2016.